Cargando…
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
The development of effective antiviral drugs targeting the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is urgently needed to combat the coronavirus disease 2019 (COVID-19). We have previously studied the use of semi-synthetic derivatives of oxysterols, oxidized derivatives o...
Autores principales: | Ohashi, Hirofumi, Wang, Feng, Stappenbeck, Frank, Tsuchimoto, Kana, Kobayashi, Chisa, Saso, Wakana, Kataoka, Michiyo, Yamasaki, Masako, Kuramochi, Kouji, Muramatsu, Masamichi, Suzuki, Tadaki, Sureau, Camille, Takeda, Makoto, Wakita, Takaji, Parhami, Farhad, Watashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003796/ https://www.ncbi.nlm.nih.gov/pubmed/33808940 http://dx.doi.org/10.3390/ijms22063163 |
Ejemplares similares
-
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021) -
Oxy210, a Semi-Synthetic Oxysterol, Inhibits Profibrotic Signaling in Cellular Models of Lung and Kidney Fibrosis
por: Wang, Feng, et al.
Publicado: (2023) -
Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties
por: Wang, Feng, et al.
Publicado: (2019) -
Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses
por: Kobayashi, Chisa, et al.
Publicado: (2022) -
Inhibition of Non-Small Cell Lung Cancer Cells by Oxy210, an Oxysterol-Derivative that Antagonizes TGFβ and Hedgehog Signaling
por: Stappenbeck, Frank, et al.
Publicado: (2019)